Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Erwin

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Journal of Neurobiology|September 30, 1999
Is the development of orientation selectivity instructed by activity?K D Miller, E Erwin, A Kayser
Diagnostic Microbiology and Infectious Disease|January 1, 1992
New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteriaR N Jones, M E Erwin, M Bale
Diagnostic Microbiology and Infectious Disease|February 1, 1996
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trialsS Worth, M E Erwin, R N Jones
SAGE Open Nursing|May 1, 2023
Physical Activity Patterns, Satisfaction, and Quality of Life Among Nursing and non-Nursing Staff in an Office-Based Care Coordination ProgramNicolas M Oreskovic, Celina Li, Ann E Erwin
Diagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N Jones
Journal of Clinical Microbiology|August 5, 2000
Determination of MIC quality control ranges for ABT-733, a novel ketolide antimicrobial agent. Quality Control Study GroupS A Marshall, M E Erwin, R N Jones
Drugs|January 1, 1995
Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centresR N Jones, E N Kehrberg, M E Erwin
International Journal of Antimicrobial Agents|August 5, 2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areasR N Jones, M A Pfaller, M E Erwin
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolonesD M Johnson, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E Erwin
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Journal of Neurobiology|September 30, 1999
Is the development of orientation selectivity instructed by activity?K D Miller, E Erwin, A Kayser
Diagnostic Microbiology and Infectious Disease|January 1, 1992
New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteriaR N Jones, M E Erwin, M Bale
Diagnostic Microbiology and Infectious Disease|February 1, 1996
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trialsS Worth, M E Erwin, R N Jones
SAGE Open Nursing|May 1, 2023
Physical Activity Patterns, Satisfaction, and Quality of Life Among Nursing and non-Nursing Staff in an Office-Based Care Coordination ProgramNicolas M Oreskovic, Celina Li, Ann E Erwin
Diagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N Jones
Journal of Clinical Microbiology|August 5, 2000
Determination of MIC quality control ranges for ABT-733, a novel ketolide antimicrobial agent. Quality Control Study GroupS A Marshall, M E Erwin, R N Jones
Drugs|January 1, 1995
Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centresR N Jones, E N Kehrberg, M E Erwin
International Journal of Antimicrobial Agents|August 5, 2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areasR N Jones, M A Pfaller, M E Erwin
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolonesD M Johnson, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E Erwin
Pageof 16